Ƶ

Psychiatry

Schizophrenia

More in Schizophrenia

Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression

News and commentary from the psychiatry world

Nov 27, 2024
Illustration of a brain shaped maze.
Opinion
If You Are Pro-Psychiatry, Should You Be Anti-RFK Jr.?

Kennedy's proposed policies are clearly anti-psychiatry

Nov 22, 2024
A photo of Robert F. Kennedy Jr.
Psych Hospitals Investigated; Internet & Well-Being; Trump's Mental Institutions

News and commentary from the psychiatry world

Nov 20, 2024
Illustration of a brain shaped maze.
Scrap Clozapine's REMS Program, FDA Advisors Say

Panel wants to reduce barriers to the only drug indicated for treatment-resistant schizophrenia

Nov 20, 2024
FDA ADCOMM clozapine over a photo of a blisterpack of yellow tablets.
Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting

Can severe neutropenia associated with the schizophrenia drug be monitored without it?

Nov 15, 2024
FDA ADCOMM clozapine over a photo of a blisterpack of yellow tablets.
1 in 5 Adults Report Anxiety, Depression; Esketamine Label Update; Autism Dx Up 175%

News and commentary from the psychiatry world

Nov 13, 2024
Illustration of a brain shaped maze.
Magnetic Stimulation Reduced Auditory Hallucinations in Patients With Schizophrenia

Clinical effects were sustained at week 6 with no serious adverse events

Nov 11, 2024
A photo of a woman receiving transcranial magnetic stimulation.
Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug

Nearly 70% of participants had at least a 30% reduction in PANSS total score by week 52

Nov 06, 2024
Psych Congress over a photo of Boston Convention & Exhibition Center in Boston, MA.
Stable Schizophrenia Not Necessarily Protective Against Relapse-Related Mortality

Database study shows estimated 5-year survival of 78% even after one relapse episode

Nov 03, 2024
PSYCH Congress
Year in Review: Tardive Dyskinesia

New VMAT2 formulations, case reports, screening tools, and long-term data in 2024

Nov 01, 2024
2024 YEAR IN REVIEW tardive dyskinesia over a computer rendering of a dendrite receiving emitted neurotransmitters.
Cymbalta Bottles Recalled; Suicides Highest on Mondays; New Dose of Pain Drug OK'd

News and commentary from the psychiatry world

Oct 30, 2024
Illustration of a brain shaped maze.
Fast-Acting Novel Depression Tx; Lumryz Label Expanded; GLP-1s for Addiction?

News and commentary from the psychiatry world

Oct 23, 2024
Illustration of a brain shaped maze.
No Single Antipsychotic Offers Cognitive Benefit in Schizophrenia Disorders

And some should be avoided when cognitive deficits are a concern, study suggests

Oct 16, 2024
A photo of a vial of Haloperidol.
15.5M Adults Have ADHD; Pediatric Social Media Harms; Loneliness Affects 1 in 5

News and commentary from the psychiatry world

Oct 16, 2024
Illustration of a brain shaped maze.
More in Schizophrenia

1.00 CME Credits
Moving Beyond Barriers: Patient-Centered Approaches to Improve Assessment, Diagnosis, and Treatment of Tardive Dyskinesia

1.00 CME Credits
Examining the Latest Clinical Evidence in New and Emerging Pharmacotherapies for Perinatal/Peripartum Depression

0.50 CME Credits
Investigating Locum Tenens Opportunities: Exposing the Benefits and Considerations

0.25 CME Credits
Examining the Pathophysiology of Perinatal and Postpartum Depression (PPD)

0.25 CME Credits
Improving the Management of Perinatal and Postpartum Depression by Applying the Latest Clinical Evidence

0.25 CME Credits
Exploring the Vital Role of Locum Tenens: Bridging Healthcare Gaps and Unveiling a Dynamic Medical Career Path

0.25 CME Credits
Developing Strategies for Assessment and Diagnosis of Bipolar I Disorder

0.50 CME Credits
Elevating MDD Care: Real-World Systems Insights and Culturally Competent Implementation Strategies